Skip to main content

Home/ Cancer/ Group items tagged docetaxel

Rss Feed Group items tagged

Matti Narkia

Cancer Journal: Latest cancer research Larynx-saving chemo combination | ecancermedical... - 0 views

    Patients with larynx cancer who received a three-drug combination of docetaxel, cisplatin and 5-fluorouracil (TPF) during induction chemotherapy were more likely to retain larynx function than were patients treated with cisplatin and 5-fluoruracil (PF) alone, according to data from a randomized controlled trial in the March 24 online issue of the Journal of the National Cancer Institute.
1 - 1 of 1
Showing 20 items per page